Nanotubes transport gene therapy drug into T-cells known to block HIV from entering cells in vitro

A promising approach to gene therapy involves short DNA fragments (interfering RNA) that bind to specific genes and block their "translation" into the corresponding, disease-related protein. A stumbling block has been the efficient and targeted delivery of RNA into the cells. Researchers led by Hongjie Dai at Stanford University have chosen to use carbon nanotubes as their "means of transport". This has allowed them to successfully introduce RNA fragments that "switch off" the genes for special HIV-specific receptors and co-receptors on the cells’ surface into human T-cells and primary blood cells. This leaves few "entry hatches" for the HIV viruses. The researchers report in the journal Angewandte Chemie that this allows for much better silencing effect to the cells than current transport systems based on liposomes. Whole article: "www.physorg.com":[ http://www.physorg.com/news91194820.html]

---

Related articles

Gene therapy for foetuses hope - The work is controversial not just because of the ethics but also safety concerns (20.3.2007)

DNA nanoparticles hold promise in gene therapy for Parkinson's disease - University of Kentucky researcher David Yurek was recently awarded $66,000 by The Michael J (3.3.2007)

All Types of Carbon Nanotubes Penetrate Wide Variety of Cell Membranes - Over the past two years, researchers have demonstrated repeatedly that certain types of carbon nanotubes are among the most effective materials known for transporting proteins, genes, and drug molecules across the cell membrane (27.2.2007)

Scientists Unveil Piece Of HIV Protein That May Be Key To AIDS Vaccine Development - In a finding that could have profound implications for AIDS vaccine design, researchers led by a team at the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health (NIH), have generated an atomic-level picture of a key portion of an HIV surface protein as it looks when bound to an infection-fighting antibody (20.2.2007)

New Weapon Against Cancer: HIV Protein Enlisted To Help Kill Cancer Cells - Cancer cells are sick, but they keep growing because they don't react to internal signals urging them to die (15.2.2007)